These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7387335)

  • 41. A treatment trial with an analog of thyrotropin-releasing hormone (DN-1417) and des-tyrosine-gamma-endorphin in schizophrenia.
    Mizuki Y; Ushijima I; Yamada M; Tanaka M; Inanaga K
    Int Clin Psychopharmacol; 1986 Oct; 1(4):303-13. PubMed ID: 2881964
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neuroleptic withdrawal in chronic schizophrenia: CT and endocrine variables relating to psychopathology.
    Naber D; Albus M; Bürke H; Müller-Spahn F; Münch U; Reinertshofer T; Wissmann J; Ackenheil M
    Psychiatry Res; 1985 Nov; 16(3):207-19. PubMed ID: 2868473
    [TBL] [Abstract][Full Text] [Related]  

  • 43. beta-Endorphin: analgesic and hormonal effects in humans.
    Foley KM; Kourides IA; Inturrisi CE; Kaiko RF; Zaroulis CG; Posner JB; Houde RW; Li CH
    Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5377-81. PubMed ID: 291954
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intravenous infusion of beta-endorphin increases serum prolactin, but not growth hormone or cortisol, in depressed subjects and withdrawing methadone addicts.
    Catlin DH; Poland RE; Gorelick DA; Gerner RH; Hui KK; Rubin RT; Li CH
    J Clin Endocrinol Metab; 1980 Jun; 50(6):1021-5. PubMed ID: 7372783
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Investigating opioid peptides in schizophrenia and depression.
    Berger PA; Watson SJ; Akil H; Barchas JD
    Res Publ Assoc Res Nerv Ment Dis; 1986; 64():309-33. PubMed ID: 2941840
    [No Abstract]   [Full Text] [Related]  

  • 46. Criteria for evaluating improvement in schizophrenia in psychopharmacological research (with special reference to gamma endorphin fragments).
    Manchanda R; Hirsch SR; Barnes TR
    Br J Psychiatry; 1988 Sep; 153():354-8. PubMed ID: 3250672
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Endogenous opiates and schizophrenia. Treatment of acute schizophrenic psychoses with beta-endorphin].
    Pethö B; Gráf L; Karczag I; Borvendég J; Bitter I; Barna I; Hermann I; Tolna J; Baraczka K
    Orv Hetil; 1980 Sep; 121(38):2307-11. PubMed ID: 6258124
    [No Abstract]   [Full Text] [Related]  

  • 48. Clinical pharmacology of beta-endorphin in depression and schizophrenia.
    Catlin DH; Gorelick DA; Gerner RH
    Ann N Y Acad Sci; 1982; 398():434-47. PubMed ID: 6297363
    [No Abstract]   [Full Text] [Related]  

  • 49. Secretion pattern of endogenous opioids in chronic schizophrenia.
    Brambilla F; Facchinetti F; Petraglia F; Vanzulli L; Genazzani AR
    Am J Psychiatry; 1984 Oct; 141(10):1183-9. PubMed ID: 6091463
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of neuroleptic treatment and of high dosage diazepam therapy on beta-endorphin immunoreactivity in plasma of schizophrenic patients.
    Gramsch C; Emrich HM; John S; Haas S; Beckmann H; Zaudig M; von Zerssen D
    J Neural Transm; 1984; 59(2):133-41. PubMed ID: 6144724
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plasma beta-endorphin levels in chronic schizophrenic patients normal controls.
    Espinosa-Meléndez E; Lal S; Nair NP; Chang TM
    Artif Organs; 1979 Nov; 3(4):375-7. PubMed ID: 533431
    [TBL] [Abstract][Full Text] [Related]  

  • 52. beta-Endorphin and schizophrenia.
    Pethö B; Gráf L; Karczag I; Bitter I; Tolna J; Baraczka K; Li CH
    Lancet; 1981 Jan; 1(8213):212-3. PubMed ID: 6109874
    [No Abstract]   [Full Text] [Related]  

  • 53. Des-enkephalin-gamma-endorphin in the treatment of schizophrenia.
    Azorin JM; Blum A; Charbaut J; Escande M; Granier F; Huber JP; Metzger JY; Richou H; Sitsen A; Van Amerongen P
    Int Clin Psychopharmacol; 1990 Jul; 5(3):205-15. PubMed ID: 2230065
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gamma-hydroxybutyrate in the treatment of schizophrenia.
    Levy MI; Davis BM; Mohs RC; Trigos GC; Mathé AA; Davis KL
    Psychiatry Res; 1983 May; 9(1):1-8. PubMed ID: 6193548
    [TBL] [Abstract][Full Text] [Related]  

  • 55. (Des-Tyr)-gamma-endorphin in the treatment of schizophrenia.
    Manchanda R; Hirsch SR
    Psychol Med; 1981 May; 11(2):401-4. PubMed ID: 6115439
    [No Abstract]   [Full Text] [Related]  

  • 56. Clozapine and risperidone in chronic schizophrenia: effects on symptoms, parkinsonian side effects, and neuroendocrine response.
    Breier AF; Malhotra AK; Su TP; Pinals DA; Elman I; Adler CM; Lafargue RT; Clifton A; Pickar D
    Am J Psychiatry; 1999 Feb; 156(2):294-8. PubMed ID: 9989566
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Beta-endorphin--induced changes in schizophrenic and depressed patients.
    Kline NS; Li CH; Lehmann HE; Lajtha A; Laski E; Cooper T
    Arch Gen Psychiatry; 1977 Sep; 34(9):1111-3. PubMed ID: 901140
    [No Abstract]   [Full Text] [Related]  

  • 58. Caffeine stimulates beta-endorphin release in blood but not in cerebrospinal fluid.
    Arnold MA; Carr DB; Togasaki DM; Pian MC; Martin JB
    Life Sci; 1982 Sep; 31(10):1017-24. PubMed ID: 6290811
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of thyrotropin-releasing hormone in chronic schizophrenic patients.
    Kobayashi K; Nakaoka K; Tsuji H; Shohmori T
    Acta Med Okayama; 1980 Sep; 34(4):263-73. PubMed ID: 6452029
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hla, and the response to treatment with gamma-type endorphins in schizophrenia.
    de Jongh BM; Verhoeven WM; van Ree JM; de Wied D; van Rood JJ
    J Immunogenet; 1982 Dec; 9(6):381-8. PubMed ID: 6186747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.